Recurrent Lung Adenocarcinoma
Also known as: Lung adenocarcinoma recurrent / Adenocarcinoma of lung recurrent
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00530 | Erlotinib | 1 / 2 | Completed | 1 |
| DB08911 | Trametinib | 1 / 2 | Completed | 1 |
| DB00958 | Carboplatin | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
| DB00642 | Pemetrexed | 2 | Active Not Recruiting | 1 |
| DB12332 | Rucaparib | 2 | Active Not Recruiting | 1 |
| DB00112 | Bevacizumab | 3 | Terminated | 1 |
| DB00958 | Carboplatin | 3 | Terminated | 1 |
| DB00002 | Cetuximab | 3 | Terminated | 1 |
| DB01229 | Paclitaxel | 3 | Terminated | 1 |